Preview

Комплексные проблемы сердечно-сосудистых заболеваний

Расширенный поиск

ВЫБОР ХИРУРГИЧЕСКОЙ ТАКТИКИ ПРИ СОЧЕТАНИЕ КОРОНАРНОГО АТЕРОСКЛЕРОЗА СО СТЕНОЗОМ АОРТАЛЬНОГО КЛАПАНА.

https://doi.org/10.17802/2306-1278-2017-1-

Аннотация

В статье представлен аналитический обзор литературных данных по проблеме сочетанного поражения аортального клапана и коронарных артерий. Изложены современные взгляды на оценку подхода к выбору методики и объему хирургического вмешательства. Отражено современное состояние проблемы эндоваскулярного лечения пациентов с сопутствующим поражением коронарных артерий при выраженном аортальном стенозе в эру транскатетерного протезирования аортального клапана.

Об авторах

Дмитрий Дмитриевич Зубарев
ФГБУ "ННИИПК им.акад. Е.Н. Мешалкина" МЗРФ
Россия
в.н.с. Центра интервенционной кардиологии


Дмитрий Александрович Хелимский
ФГБУ "ННИИПК им.акад. Е.Н. Мешалкина" МЗРФ
Россия
в.н.с. Центра интервенционной кардиологии


Список литературы

1. Список литературы

2. Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol 1988;62:117 – 120.

3. Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012;60:169 – 180.

4. Stewart BF,Siscovick D, Lind BK,Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630–634.

5. Lung B. Interface between valve disease and ischaemic heart disease. Heart 2000;84: 347 – 352.

6. Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия – 2014. НЦ. ССХ им. А.Н. Бакулева РАМН. М 2015.

7. Bokeriya L.A., Gudkova R.G. Serdechno-sosudistaya khirurgiya– 2014. NTs. SSKh im. A.N. Bakuleva RAMN. M 2015.

8. Adler Y, Vaturi M, Herz I, Iakobishvili Z, Toaf J, Fink N, Battler A, Sagie A. Nonobstructive aortic valve calcification: a window to significant coronary artery disease. Atherosclerosis 2002;161:193 – 197.

9. Kvidal P, Bergstrom R, Horte LG ,Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747 – 756.

10. Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol 1983;51:1005–1028.

11. Thubrikar MJ, Deck JD, Aouad J, Chen JM. Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve. Atherosclerosis 1985;55:299 – 311.

12. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Lung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology, ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451 – 2496.

13. Aranki S,Rizzo R,Couper G,Adams D,Collins J,Gildea J,Kinchla N,Cohn L. Aortic valve replacement in the elderly: effect of gender and coronary artery disease on operative mortality. Circulation 1992;88:17 – 23.

14. Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, Svensson LG, Tuzcu M, Webb JG, Cribier A, Mack MJ. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010;89:758 – 767.

15. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD. 2014 AHA/ACC Guideline for the Management of Patients with Valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;14:735–1097.

16. Hannan EL, Wu C, Bennett EV, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007; 83:921–9.

17. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in northern New England. Ann Thorac Surg 2004;77:1966–77.

18. Kuduvalli M, Grayson AD, Au J, Grotte G, Bridgewater B, Fabri BM. A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg 2007;31: 607–13.

19. Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, Johnston DR, Sabik JF III, Blackstone EH. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 2013;61:837 – 848.

20. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, Bajaj N, Joseph L, Patel NS, Aksoy O, Stewart WJ, Griffin BP, Kapadia SR. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation 2012;125:1005–1013.

21. Paradis JM, Fried J, Nazif T, Kirtane A, Kishore Harjai, Omar Khalique, Kendra Grubb, Isaac George, Rebecca Hahn, Mathew Williams, Martin B. Leon, and Susheel Kodali Aortic stenosis and coronary artery disease: What do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms European Heart Journal (2014) 35, 2069–2082 doi:10.1093/eurheartj/ehu247

22. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn LH. Staged initial percutaneous coronary intervention followed by valve surgery (‘hybrid approach’) for patients with complex coronary and valve disease. J Am Coll Cardiol 2005;45:14 – 18.

23. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, Cohn LH. Effectiveness of same day percutaneous coronary intervention followed by minimally in- vasive aortic valve replacement for aortic stenosis and moderate coronary disease (‘hybrid approach’). Am J Cardiol 2006;98:1501–1503.

24. Santana O, Funk M, Zamora C, Escolar E, Lamas GA, Lamelas J. Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg 2012;144:634 – 639.

25. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607.

26. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364: 2187–98.

27. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366:1705–15.

28. Dewey TM, Brown DL, Das TS, et al. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 2008;86:1450–6; discussion 6–7.

29. Kapadia SR, Goel SS, Svensson L, et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009;137: 1430–5.

30. Gasparetto V, Fraccaro C, Tarantini G, Buja P, D’Onofrio A, Yzeiraj E, Pittarello D, Isabella G, Gerosa G, Iliceto S, Napodano M. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013;81:376–383.

31. Abdel-Wahab M, Mostafa AE, Geist V, et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol 2012;109:581–6.

32. Mostafa AE, Geist V, Abdel-Wahab M. Ad-hoc percutaneous coronary intervention and transcatheter aortic valve implantation as a combined transfemoral procedure. J Invasive Cardiol 2011;23: E102–5.

33. Pasic M, Dreysse S, Unbehaun A, et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012;14:463–8.

34. Wenaweser P, Pilgrim T, Guerios E, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011;7:541–8.

35. Малоинвазивный гибридный подход к реваскуляризации миокарда. Попов В.А., Ганюков В.И., Козырин К.А., Хаес Б.Л., Григорьев Е.В., Моисеенков Г.В., Барабаш Л.С. Кардиология и сердечно- сосудистая хирургия. 2013.Т.6. №6. С 4-8.

36. Maloinvazivnyy gibridnyy podkhod k revaskulyarizatsii miokarda. Popov V.A., Ganyukov V.I., Kozyrin K.A., Khaes B.L., Grigor'ev E.V., Moiseenkov G.V., Barabash L.S. Kardiologiya i serdechno- sosudistaya khirurgiya. 2013.T.6. №6. S 4-8.


Дополнительные файлы

1. Алгоритм ведения пациентов с клапанной патологией в сочетании с ИБС.
Тема
Тип Исследовательские инструменты
Скачать (520KB)    
Метаданные

Для цитирования:


Зубарев Д.Д., Хелимский Д.А. ВЫБОР ХИРУРГИЧЕСКОЙ ТАКТИКИ ПРИ СОЧЕТАНИЕ КОРОНАРНОГО АТЕРОСКЛЕРОЗА СО СТЕНОЗОМ АОРТАЛЬНОГО КЛАПАНА. Комплексные проблемы сердечно-сосудистых заболеваний. 2017;(1). https://doi.org/10.17802/2306-1278-2017-1-

For citation:


., . Complex Issues of Cardiovascular Diseases. 2017;(1). https://doi.org/10.17802/2306-1278-2017-1-

Просмотров: 99


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)